Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219
Etoricoxib Tablets

Etoricoxib Tablet Manufacturer, Supplier & Exporter

Etoricoxib Tablets 90 mg: Each film-coated tablet contains Etoricoxib 90 mg.

Usage: Relief of pain and inflammation in approved indications.

Category: Anti Analgesic Painkiller Drugs

Therapeutic category: Selective COX-2 NSAID, Analgesic

SKU: Etoricoxib Tablets

Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations

Product Information

Etoricoxib Tablet Manufacturer, Supplier & Exporter is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.

For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.

Description

Etoricoxib Tablets (90 mg; other registered strengths 60 mg / 120 mg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. manufactures Etoricoxib Tablets in India. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor used for certain painful inflammatory conditions under medical supervision. Its use and permitted indications vary by country. COX-2 selectivity may reduce some upper gastrointestinal complications compared with certain traditional NSAIDs, but it does not eliminate ulcer, bleeding, cardiovascular or kidney risks.

2. Product Specifications

ParameterSpecification
ProductEtoricoxib Film-Coated Tablets
Primary compositionEach film-coated tablet contains Etoricoxib 90 mg
Other strengths60 mg / 120 mg, where separately registered
Therapeutic classSelective COX-2 inhibitor / NSAID
Dosage formFilm-coated oral tablet
Quality standardApplicable registered IP / BP / EP specification
PackagingRegistered blister or bottle presentation
Shelf lifeAccording to validated stability data

3. Manufacturing Technology

Film coating, excipient selection and validated manufacturing controls support tablet uniformity, dissolution and stability. The pharmacological COX-2 selectivity is a property of the active molecule, not created by tablet coating. Release profiles, appearance and packaging are formulation-specific; rapid pain relief at an exact minute cannot be guaranteed.

4. Quality Assurance

Quality testing may include identification, assay, content uniformity, dissolution, related substances and stability according to the approved specifications. Numerical limits must be taken from the registered product specification rather than applied universally.

5. Pharmacology and Indications

Etoricoxib inhibits COX-2-mediated prostaglandin synthesis and can reduce pain and inflammation. Depending on local approval, indications may include osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout and short-term dental pain. It is not appropriate for every patient or every type of pain.

6. Export and Regulatory Support

Product-specific CTD/ACTD dossiers, bioequivalence evidence, certificates of analysis and other regulatory documentation may be available subject to registration and verification. Export destinations and packaging must comply with the importing market’s authorization. Etoricoxib is not approved for marketing in the United States.

7. Frequently Asked Questions

Who manufactures Etoricoxib Tablets?
Healthy Life Pharma Pvt. Ltd., India.

Is it Arcoxia?
Arcoxia is a brand of etoricoxib. Generic equivalence or interchangeability requires applicable regulatory evidence.

Is it safer for the stomach?
Some gastrointestinal risks may be lower than with certain nonselective NSAIDs, but serious bleeding and ulcers can still occur.

Can patients with heart disease take it?
It can increase cardiovascular risk and is contraindicated in several cardiovascular conditions under many labels. A clinician must assess suitability.

8. Dosage and Administration

Dose and duration depend on the approved indication, patient factors and local product label. Use the lowest effective dose for the shortest possible duration. The 90 mg tablet must not be assumed appropriate for all pain conditions; do not self-medicate or combine with other NSAIDs without clinical advice.

9. Side Effects and Precautions

  • Cardiovascular: Blood pressure elevation, fluid retention, heart attack and stroke risks require careful assessment; avoid in patients with contraindicated cardiovascular disease or uncontrolled hypertension.
  • Gastrointestinal: Indigestion, ulceration and potentially serious bleeding may occur.
  • Kidney and liver: Renal impairment and liver enzyme abnormalities can occur; monitoring may be appropriate.
  • Pregnancy: NSAIDs carry important fetal risks, particularly later in pregnancy; use only in accordance with prescribing information.
  • Interactions: Review anticoagulants, antihypertensives, diuretics, other NSAIDs and relevant medicines.

10. Storage Instructions

Store according to the registered label, protected from excessive heat and moisture, and keep out of reach of children.